This study was also the first to report the incidence of EGFR mutation-specific lung cancer in Māori and Pacifica, the populations of interest in New Zealand, revealing that these populations had increased risk of developing EGFR mutation-positive lung cancer, as seen for lung cancer overall [44–47]. This evidence concerns the gene EGFR and lung carcinoma.